GSA CAPITAL PARTNERS LLP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 111 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$785
-99.8%
3,240
-32.2%
0.08%
+52.9%
Q4 2021$405,000
-44.6%
4,780
-47.8%
0.05%
-31.1%
Q3 2021$731,000
+50.1%
9,156
+83.0%
0.07%
+34.5%
Q2 2021$487,000
+31.3%
5,003
+50.1%
0.06%
-9.8%
Q4 2020$371,000
-66.7%
3,334
-72.8%
0.06%
-53.1%
Q4 2019$1,115,000
+251.7%
12,241
+232.9%
0.13%
+202.3%
Q3 2019$317,000
-33.4%
3,677
+116.0%
0.04%
+79.2%
Q2 2018$476,0001,7020.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders